One notable aspect of the TNBC immune microenvironment is the presence of immunosuppressive elements, which can hinder the effective anti-tumor immune response.19 TNBC tumors may express immune checkpoint molecules, such as programmed death-ligand 1 (PD-L1). The gene discussed is CD274; the disease is neoplasm.